Хайлтын үр дүнгүүд - Sandra Garcet
- 24-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
-
2
-
3
-
4
The effect of subcutaneous brodalumab on clinical disease activity in hidradenitis suppurativa: An open-label cohort study -н John W. Frew, Kristina Navrazhina, David Grand, Mary Sullivan‐Whalen, Patricia Gilleaudeau, Sandra Garcet, Jonathan Ungar, James G. Krueger
Хэвлэсэн 2020Artigo -
5
-
6
Autoantigens <scp>ADAMTSL</scp>5 and <scp>LL</scp>37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes -н Judilyn Fuentes‐Duculan, Kathleen M. Bonifacio, Jason E. Hawkes, Norma Kunjravia, Inna Cueto, Xuan Li, Juana Gonzalez, Sandra Garcet, James G. Krueger
Хэвлэсэн 2017Artigo -
7
Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis -н Lewis E. Tomalin, Chris B. Russell, Sandra Garcet, David Ewald, Paul Klekotka, Ajay Nirula, Hanne Norsgaard, Mayte Suárez‐Fariñas, James G. Krueger
Хэвлэсэн 2019Artigo -
8
An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease -н Benjamin Ungar, Sandra Garcet, Juana Gonzalez, Nikhil Dhingra, Joel Corrêa da Rosa, Avner Shemer, James G. Krueger, Mayte Suárez‐Fariñas, Emma Guttman‐Yassky
Хэвлэсэн 2016Artigo -
9
Modulation of inflammatory gene transcripts in psoriasis vulgaris: Differences between ustekinumab and etanercept -н Carrie Brodmerkel, Katherine Li, Sandra Garcet, Karen Hayden, Andrea Chiricozzi, Inna Novitskaya, Judilyn Fuentes‐Duculan, Mayte Suárez‐Fariñas, Kim Campbell, James G. Krueger
Хэвлэсэн 2019Carta -
10
Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis -н Patrick Baum, Sudha Visvanathan, Sandra Garcet, Janine Roy, Ramona Schmid, Sebastian Bossert, Benjamin Lang, H. Bachelez, Robert Bissonnette, Christian Thoma, James G. Krueger
Хэвлэсэн 2021Artigo -
11
Novel immune signatures associated with dysplastic naevi and primary cutaneous melanoma in human skin -н Bernice Y. Yan, Sandra Garcet, Nicholas Gulati, Felix Kiecker, Judilyn Fuentes‐Duculan, Patricia Gilleaudeau, Mary Sullivan‐Whalen, Avner Shemer, Hiroshi Mitsui, James G. Krueger
Хэвлэсэн 2018Artigo -
12
Signalling of multiple interleukin (IL)‐17 family cytokines via IL‐17 receptor A drives psoriasis‐related inflammatory pathways -н Maxim A. X. Tollenaere, Josephine B. Hebsgaard, David Ewald, Paola Lovato, Sandra Garcet, Xuan Li, Steven Pilger, Minna Lund Tiirikainen, M. Bertelsen, James G. Krueger, Hanne Norsgaard
Хэвлэсэн 2021Artigo -
13
Reduction of Inflammatory and Cardiovascular Proteins in the Blood of Patients with Psoriasis: Differential Responses between Tofacitinib and Etanercept after 4 Weeks of Treatment -н Jaehwan Kim, Lewis E. Tomalin, Julie Lee, Lori Fitz, Gabriel Berstein, Joel Corrêa da Rosa, Sandra Garcet, Michelle A. Lowes, Hernán Valdez, Robert Wołk, Mayte Suárez‐Fariñas, James G. Krueger
Хэвлэсэн 2017Artigo -
14
Phase 2a randomized clinical trial of dupilumab (anti‐IL‐4Rα) for alopecia areata patients -н Emma Guttman‐Yassky, Yael Renert‐Yuval, Jennifer Bares, Margot Chima, Jason E. Hawkes, Patricia Gilleaudeau, Mary Sullivan‐Whalen, Giselle Singer, Sandra Garcet, Ana B. Pavel, Mark Lebwohl, James G. Krueger
Хэвлэсэн 2021Artigo -
15
Gram‐negative anaerobes elicit a robust keratinocytes immune response with potential insights into <scp>HS</scp> pathogenesis -н Samuel C. Williams, Sandra Garcet, Hong Hur, Shunsuke Miura, Juana Gonzalez, Kristina Navrazhina, Mika Yamamura‐Murai, Kazuhiko Yamamura, Xuan Li, John W. Frew, Vincent A. Fischetti, Uri Sela, James G. Krueger
Хэвлэсэн 2024Artigo -
16
Molecular and Cellular Responses to the TYK2/JAK1 Inhibitor PF-06700841 Reveal Reduction of Skin Inflammation in Plaque Psoriasis -н Karen Page, Mayte Suárez‐Fariñas, Maria Suprun, Weidong Zhang, Sandra Garcet, Judilyn Fuentes‐Duculan, Xuan Li, Matthew Scaramozza, Elizabeth Kieras, Christopher Banfield, James D. Clark, Andrew Fensome, James G. Krueger, Elena Peeva
Хэвлэсэн 2020Artigo -
17
Psoriatic skin molecular and histopathologic profiles after treatment with risankizumab versus ustekinumab -н Sudha Visvanathan, Patrick Baum, Richard Vinisko, Ramona Schmid, Mary Flack, Bojan Lalovic, Oliver Kleiner, Judilyn Fuentes‐Duculan, Sandra Garcet, J. Wade Davis, Kristie M. Grebe, Jay S. Fine, Steven J. Padula, James G. Krueger
Хэвлэсэн 2018Artigo -
18
Bimekizumab for the treatment of moderate‐to‐severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double‐... -н Ruth Oliver, James G. Krueger, Sophie Glatt, Pavan Vajjah, Catrina Mistry, Matthew Page, Hannah B Edwards, Sandra Garcet, Xuan Li, Benjamin Dizier, A. Maroof, Mark Watling, Assem el Baghdady, Dominique Baeten, Lucian Ionescu, Stevan Shaw
Хэвлэсэн 2021Artigo -
19
Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata -н Yael Renert‐Yuval, Ana B. Pavel, Ester Del Duca, Paola Facheris, Angel D. Pagan, Swaroop Bose, P. Gomez-Arias, Michael Angelov, Jennifer Bares, Margo Chima, Yeriel Estrada, Sandra Garcet, Mark Lebwohl, James G. Krueger, Emma Guttman‐Yassky
Хэвлэсэн 2022Artigo -
20
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis -н Lisa Zhou, Alexandra Leonard, Ana B. Pavel, Kunal Malik, Aishwarya Raja, Jacob W. Glickman, Yeriel Estrada, Xiangyu Peng, Ester Del Duca, Juan Luís Sanz-Cabanillas, Juan Ruano, Hui Xu, Ning Zhang, Huei‐Chi Wen, Juana Gonzalez, Sandra Garcet, James G. Krueger, Emma Guttman‐Yassky
Хэвлэсэн 2019Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Immunology
Internal medicine
Dermatology
Psoriasis
Biology
Pathology
Disease
Inflammation
Atopic dermatitis
Alternative medicine
Cancer research
Chemokine
Gastroenterology
Gene
Hidradenitis suppurativa
Immune system
Placebo
Tumor necrosis factor alpha
Cytokine
Genetics
Ustekinumab
Biochemistry
Chemokine receptor
Dermatology Life Quality Index
Infliximab
Interleukin 17
Pathogenesis
Psoriasis Area and Severity Index
Randomized controlled trial